SS
MYGN icon

SBI Securities’s Myriad Genetics MYGN Stock Holding History

SBI Securities’s Portfolio MYGN Stock Details MYGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6.29K Buy
1,101
+96
+10% +$436 ﹤0.01% 2073
2026
Q1 		$4.52K Buy
1,005
+4
+0.4% +$21 ﹤0.01% 2067
2025
Q4 		$6.16K Buy
1,001
+996
+19,920% +$7.22K ﹤0.01% 1940
2025
Q3 		$36 Sell
5
-123
-96% -$730 ﹤0.01% 3797
2025
Q2 		$680 Buy
128
+15
+13% +$89 ﹤0.01% 2838
2025
Q1 		$1K Buy
113
+9
+9% +$108 ﹤0.01% 2584
2024
Q4 		$1.43K Buy
+104
New +$1.92K ﹤0.01% 2441

Other funds holding MYGN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

SBI Securities's MYGN Position: Q2 2026 in Review

SBI Securities increased its Myriad Genetics (MYGN) stake by 9.6% in Q2 2026, buying an estimated $436 and bringing the position to 1,101 shares worth $6.29K. The position accounts for ﹤0.01% of the portfolio, ranked #2073.

SBI Securities first reported a position in MYGN in Q4 2024 and has held it in 7 quarters since. 196 funds tracked by Wall St. Rank hold MYGN as of Q2 2026.

  • SBI Securities held 1,101 shares of Myriad Genetics worth $6.29K as of Q2 2026.
  • SBI Securities bought 96 Myriad Genetics shares in Q2 2026, an estimated $436.
  • Myriad Genetics made up ﹤0.01% of SBI Securities's portfolio in Q2 2026, its #2073 holding.
  • SBI Securities first reported a position in Myriad Genetics in Q4 2024 and has held it in 7 quarters since.
  • 196 funds tracked by Wall St. Rank held Myriad Genetics as of Q2 2026.

Based on SBI Securities's 13F filing for Q2 2026, filed 23 Jul 2026.